Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Rang in Aktien #40
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Aktienkurs
$481.73
Marktkapitalisierung
$377.65B
Veränderung (1 Tag)
-0.96%
Veränderung (1 Jahr)
50.07%
Land
CH
Handel Roche Holding AG (RO)

Kategorie

EPS für Roche Holding AG (RO)
EPS zum December 2025 TTM: $20.39
Laut den aktuellen Finanzberichten und dem Aktienkurs von Roche Holding AG beträgt das aktuelle EPS des Unternehmens (TTM) $20.39. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Roche Holding AG von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$29.85 46.40%
US
$8.65 -57.58%
US
$3.55 -82.59%
US
$1.26 -93.82%
US
$7.19 -64.74%
CH